Stage III Colon Cancer AJCC v7

general

Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6

49

Centers

62

Active Trials

$5.7B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Stage III Colon Cancer AJCC v7(49)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
51.5
2
NCI Comprehensive
51.5
351.5
451.5
551.5
651.5
7
NCI Comprehensive
51.5
8
NCI Comprehensive
51.5
9
NCI Comprehensive
51.5
10
NCI Comprehensive
51.5
11
NCI Comprehensive
51.5
12
NCI Comprehensive
51.5
1351.5
14
NCI Comprehensive
51.5
1551.5
1651.5
17
NCI Comprehensive
51.5
18
NCI Comprehensive
51.5
19
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
51.5
2051.5
2151.5
2251.5
2351.5
24
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
51.5
25
NCI Comprehensive
51.5
2651.5
2751.5
2851.5
2951.5
3051.5
3151.5
3251.5
3351.5
34
NCI Comprehensive
35
NCI Comprehensive
36
NCI Comprehensive
37
NCI Comprehensive
38
NCI Comprehensive
39
NCI Comprehensive
40
41
NCI Comprehensive
42
NCI Comprehensive
43
44
Cedars-Sinai CancerLos Angeles, CA
45
NCI Comprehensive
46
47
48
49

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →